Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 854.74M P/E - EPS this Y 3.50% Ern Qtrly Grth -
Income -55.74M Forward P/E -16.72 EPS next Y 6.50% 50D Avg Chg -23.00%
Sales 177.13M PEG -0.78 EPS past 5Y - 200D Avg Chg -48.00%
Dividend N/A Price/Book 5.50 EPS next 5Y 16.20% 52W High Chg -62.00%
Recommedations 2.40 Quick Ratio 6.77 Shares Outstanding 39.17M 52W Low Chg 12.00%
Insider Own 5.94% ROA -13.85% Shares Float 38.29M Beta 1.48
Inst Own 106.96% ROE -35.39% Shares Shorted/Prior 4.14M/3.72M Price 22.07
Gross Margin 71.75% Profit Margin -31.47% Avg. Volume 935,798 Target Price 20.17
Oper. Margin -30.40% Earnings Date Apr 30 Volume 1,457,113 Change -3.67%
About Silk Road Medical, Inc.

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Silk Road Medical, Inc. News
04/23/24 Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
04/23/24 All You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
04/09/24 Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
04/08/24 Silk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
04/02/24 Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
03/22/24 Silk Road Medical (SILK) Upgraded to Buy: What Does It Mean for the Stock?
03/07/24 Silk Road Medical's (SILK) New Stent Expands Its TCAR Portfolio
03/05/24 Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
03/02/24 Silk Road Medical, Inc (NASDAQ:SILK) Released Earnings Last Week And Analysts Lifted Their Price Target To US$18.43
03/01/24 Silk Road Medical Full Year 2023 Earnings: Beats Expectations
02/29/24 Silk Road Medical, Inc (NASDAQ:SILK) Q4 2023 Earnings Call Transcript
02/29/24 Q4 2023 Silk Road Medical Inc Earnings Call
02/28/24 Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
02/28/24 Silk Road Medical Inc (SILK) Reports Growth Amidst Increased Adoption of TCAR
02/28/24 Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
02/07/24 Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
01/22/24 Silk Road Medical (SILK) Stock Jumps 12.7%: Will It Continue to Soar?
04:40 AM Here’s Why Silk Road Medical (SILK) Came Under Pressure Despite 37% Growth
12/21/23 Here’s Why Silk Road Medical (SILK) Detracted in Q3
12/20/23 Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SILK Chatroom

User Image Stock_Titan Posted - 2 days ago

$SILK Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference https://www.stocktitan.net/news/SILK/silk-road-medical-to-present-at-the-bof-a-securities-2024-healthcare-inf1098gsarn.html

User Image net0trader Posted - 3 days ago

@MaverikIT @RonIsWrong @Im_not_Mr_Lebowski @DonCorleone77 @Wigglyick @Cash4freedom @IsabellaDC really liking this chart here $SILK

User Image LoyalShark Posted - 1 week ago

$NSPR $SILK $MDT $JNJ will have to buy NSPR or order from them. NO ONE wants a 2nd ..3rd in class stent in them. InspireMD (NSPR) The BEST idea in MedTech PERIOD. No debt. Trial results end of May. Already announced the 30 day results and they were FREAKEN STELLAR - 1st in class by a LOT. OVER 50,000 stents already placed. HISTORIC EXPANDED CMS (medicare/medicaid) coverage Oct 2024 opens HUGE push towards stenting over endarterectomy (cut and pasting arteries) $17 mil milestone payment after May results. The whose who of biotech are in the stock. HEAVY INSTITUTIONAL OWNERSHIP for a microcap. I like NSPR. A lot.

User Image Bio_Be_Dirty Posted - 1 week ago

$SILK due for a drop or continuation

User Image StockConsultant Posted - 2 weeks ago

$SILK Road Medical stock breakout watch above 19.45 , https://stockconsultant.com/?SILK

User Image Stock_Titan Posted - 2 weeks ago

$SILK Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024 https://www.stocktitan.net/news/SILK/silk-road-medical-to-report-first-quarter-2024-financial-results-on-wte97vi2g10l.html

User Image MakingMeMeoutofME Posted - 2 weeks ago

$MLSS was attending the ASIPP in Dallas this week https://asipp.org/wp-content/uploads/0424-AnnualMeeting-brochure.pdf lots of pain management teams attending and big corporate heavyweights. Compuflo is going to gain ground sooner than later 2H 2024 could be our time $TNDM 2-80 $SILK

User Image MakingMeMeoutofME Posted - 3 weeks ago

$MLSS needs to overhaul their entire IR PR teams and start telling their story. The good news no one is paying attention to their reimbursement processes which makes the stock a steal if when they land commercial insurance companies and/or medicare. we could have a triple in a matter of any given week. $TNDM $SILK

User Image briefingcom Posted - 3 weeks ago

$SILK: Silk Road Medical +2.5% making a strong move after announcing last night the launch of its ENROUTE Transcarotid NPS PLUS, a key component of the TCAR portfolio

User Image Stock_Titan Posted - 3 weeks ago

$SILK Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS https://www.stocktitan.net/news/SILK/silk-road-medical-strengthens-tcar-portfolio-with-launch-of-enroute-nupr4yrleyvh.html

User Image StockInvest_us Posted - 1 month ago

Signal alert: $SILK - Overbought Trend Short (Overvalued) https://stockinvest.us/l/wluOc2PJuz

User Image StockConsultant Posted - 1 month ago

$SILK Silk Road Medical stock nice bounce off 15.76 support area, from Stocks To Watch , see https://stockconsultant.com/?SILK

User Image LoyalShark Posted - 1 month ago

@GiveHerTheDD It makes no sense. Its virtually impossible to get anyone on the phone to ask a question. Craig Shore --- no respect for that guys communication at all. Marvin is a market amateur. Not saying that to be mean - its a fact. He totally sucks at the market. He doesn't have a clue and worse , probably thinks its 'no big deal' his stock trades like a POS. 15-20 cent spread. UN FKN believable. This dude on the IR side - Chucky -- what a farse. IFFFF the story is THAT GOOD you would THINK it would be a slam dunk getting, at least, the same analysts that follow $SILK to follow you. I wanted to intro them to Raymond James - 25 calls and not 1 freaken returned call. I dont remember being this frustrated with a company in a long time. That they are in Isreal -- I will NEVER invest in anouther Isreali company as long as i live. I have 2 of them now and BOTH are freaken maddening in how they communicate.

User Image TubTrader101 Posted - 1 month ago

@RentFree ooo what's $Silk? Going to bed but give me a rundown, guessing it's not the medical group 🙃

User Image RentFree Posted - 1 month ago

@battlechaser24 also $SILK is gonna be so dope

User Image Mustbeaway11 Posted - 1 month ago

$SILK this might pop tomorrow?

User Image Stock_Titan Posted - 1 month ago

$SILK Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China https://www.stocktitan.net/news/SILK/advancing-healthcare-access-genesis-med-tech-teams-up-with-silk-road-gk84fvc2hqw0.html

User Image LoyalShark Posted - 1 month ago

$SILK $ABT $MDT Either Silk, Abbot, Medtronics buys $NSPR or will they will be buying $NSPR's 1st in class stent. Who wants a 2nd, 3rd, 4th, 10th best stent when its your life. No one 🧐 $NSPR's C-Guard EPS micromesh coming to an artery near you ...soon.

User Image LoyalShark Posted - 1 month ago

$SILK If you love $Silk.....you HAVE TO look at $NSPR $NSPR is the one that will be eating $silk 's lunch soon. Or maybe $SILK just buys $NSPR to obtian the 1st inclass cortotid artery stent CGuard? $SILK has the TCAR system that yearns for a 1st in class stent like CGUARD. Bullish on both --- but if you own $SILK -- you should be owning $NSPR as well.

User Image insiderbuyingselling Posted - 1 month ago

$SILK new insider buying: 11700 shares. http://insiderbuyingselling.com/?t=SILK

User Image _tr8dr_ Posted - 1 month ago

$SILK why the big pull back today?

User Image Stock_Titan Posted - 1 month ago

$SILK Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System https://www.stocktitan.net/news/SILK/silk-road-medical-expands-tcar-r-portfolio-with-launch-of-tapered-gs1gvaw41rf3.html

User Image Elledoeshair Posted - 1 month ago

$SILK

User Image G101SPM Posted - 1 month ago

$SILK $17.73 bid. SELL/TAKE PROFIT ABOVE EXIT POINT. DAC $11.42 (1.3.24).

User Image swingingtech Posted - 02/29/24

$RNA $CPRX $SILK https://wallstreetwaves.com/top-3-health-care-stocks-you-may-want-to-dump-in-q1/

User Image Ninja_Tradez Posted - 02/29/24

📢 $SILK - JP Morgan Maintains Neutral on Silk Road Medical, Raises Price Target to $19 https://newsfilter.io/a/21831d0a1840a7f892fdccd730f21e7f

User Image OpenOutcrier Posted - 02/29/24

$SILK (+15.0% pre) Silk Road Medical GAAP EPS of -$0.33 beats by $0.06, revenue of $47.27M beats by $5.26M https://seekingalpha.com/news/4073504-silk-road-medical-gaap-eps-of-0_33-beats-0_06-revenue-of-47_27m-beats-5_26m

User Image DonCorleone77 Posted - 02/28/24

$SILK Silk Road Medical sees FY24 revenue $194M-$198M, consensus $191.65M Silk Road Medical projects revenue for the full year 2024 to range from $194M to $198M...

User Image DonCorleone77 Posted - 02/28/24

$SILK Silk Road Medical reports Q4 EPS (33c), consensus (42c) Reports Q3 revenue $$47.27M , consensus $$41.97M . Reports adjusted EBITDA was a loss of $4.1M for the fourth quarter of 2023 compared to a loss of $4.4 M for the fourth quarter of 2022."With the right team in place, broad reimbursement, and extensive evidence in support of TCAR, we are laser focused on deepening adoption in physicians who perform TCAR," said Chas McKhann, CEO of Silk Road Medical. "My experience thus far at Silk Road has only served to further validate the vast opportunity that we see for TCAR to benefit many more patients with carotid artery disease, and I'm excited by the underlying progress we are already making towards that end."

User Image epsguid Posted - 02/28/24

$SILK reported a loss of $0.33, consensus was ($0.40) via @eWhispers #epsbeat http://eps.sh/d/silk

Analyst Ratings
Argus Research Buy Mar 7, 24
Stifel Buy Feb 29, 24
JP Morgan Neutral Feb 29, 24
Piper Sandler Neutral Feb 29, 24
Stifel Buy Jan 19, 24
Lake Street Buy Jan 3, 24
Wolfe Research Peer Perform Oct 24, 23
Piper Sandler Neutral Oct 11, 23
CL King Neutral Oct 11, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Jones Marie L. CAO and VP, Finance CAO and VP, Finance Oct 27 Sell 6.607 656 4,334 54,941 10/30/23
Buchanan Lucas W. COO/CFO COO/CFO Oct 04 Sell 15.223 2,662 40,524 435,848 10/06/23
Rogers Erica J. President and CEO President and CEO Mar 02 Sell 56.6189 1,651 93,478 267,988 09/29/23
Klemz Kevin M EVP/Chief Legal Offi.. EVP/Chief Legal Officer/Sec. Aug 17 Sell 20.105 1,539 30,942 38,797 08/18/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer May 19 Sell 22.13 6,587 145,770 109,534 08/04/23
Buchanan Lucas W. COO/CFO COO/CFO May 19 Option 10.8 9,643 104,144 215,725 07/31/23
Jones Marie L. CAO and VP, Finance CAO and VP, Finance May 19 Option 6.11 2,000 12,220 48,002 07/21/23
Rogers Erica J. President and CEO President and CEO Jul 11 Sell 31.56 1,000 31,560 269,639 07/13/23
Rogers Erica J. President and CEO President and CEO Jul 11 Option 1.6 1,000 1,600 270,639 07/13/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Jul 06 Sell 30.787 69 2,124 115,614 07/10/23
Rogers Erica J. President and CEO President and CEO May 19 Sell 32.13 1,000 32,130 269,639 06/13/23
Rogers Erica J. President and CEO President and CEO May 19 Option 1.6 1,000 1,600 270,639 06/13/23
Rogers Erica J. President and CEO President and CEO May 11 Sell 35.51 3,000 106,530 269,132 05/12/23
Rogers Erica J. President and CEO President and CEO May 11 Option 1.6 3,000 4,800 272,132 05/12/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer May 01 Sell 44.51 6,753 300,576 115,683 05/03/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer May 01 Option 8.89 6,753 60,034 122,436 05/03/23
WEATHERMAN ELIZABETH H Director Director Apr 17 Sell 41.91 5,000 209,550 144,454 04/19/23
Rogers Erica J. President and CEO President and CEO Apr 11 Sell 39.77 6,000 238,620 269,132 04/12/23
Rogers Erica J. President and CEO President and CEO Apr 11 Option 1.6 6,000 9,600 275,132 04/12/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Apr 03 Sell 39.42 6,753 266,203 115,683 04/05/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Apr 03 Option 5.19 6,753 35,048 122,436 04/05/23
WEATHERMAN ELIZABETH H Director Director Mar 15 Sell 41.91 5,000 209,550 149,454 03/17/23
Rogers Erica J. President and CEO President and CEO Mar 13 Sell 42.23 6,000 253,380 269,132 03/15/23
Rogers Erica J. President and CEO President and CEO Mar 13 Option 1.6 6,000 9,600 275,132 03/15/23
Ruedy Richard EVPClin&Reg.Affa.. EVPClin&Reg.Affairs&QA Mar 02 Sell 47.73 2,373 113,263 145,483 03/06/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Mar 02 Sell 47.74 3,868 184,658 115,683 03/06/23
Buchanan Lucas W. COO/CFO COO/CFO Mar 02 Sell 47.11 9,918 467,237 205,575 03/06/23
Rogers Erica J. President and CEO President and CEO Mar 02 Sell 47.1 18,043 849,825 269,132 03/06/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Mar 01 Sell 48.02 6,753 324,279 98,205 03/02/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Mar 01 Option 4.73 6,753 31,942 99,019 03/02/23
WEATHERMAN ELIZABETH H Director Director Feb 15 Sell 49.86 5,000 249,300 154,454 02/17/23
Rogers Erica J. President and CEO President and CEO Feb 13 Sell 50.94 6,000 305,640 246,199 02/15/23
Rogers Erica J. President and CEO President and CEO Feb 13 Option 1.6 6,000 9,600 252,199 02/15/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Feb 01 Sell 54.05 6,753 365,000 98,205 02/03/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Feb 01 Option 4.73 6,753 31,942 104,958 02/03/23
Chou Tony M. Director Director Feb 01 Sell 55 13,008 715,440 75,707 02/03/23
Buchanan Lucas W. COO/CFO COO/CFO Jan 17 Sell 53.72 86,244 4,633,028 188,811 01/19/23
Buchanan Lucas W. COO/CFO COO/CFO Jan 17 Option 7.73 83,528 645,671 217,289 01/19/23
WEATHERMAN ELIZABETH H Director Director Jan 17 Sell 54.693 56,355 3,082,224 159,454 01/19/23
Chou Tony M. Director Director Jan 12 Sell 55 1,006 55,330 87,709 01/17/23
Rogers Erica J. President and CEO President and CEO Jan 11 Sell 51.53 6,000 309,180 246,199 01/13/23
Rogers Erica J. President and CEO President and CEO Jan 11 Option 1.6 6,000 9,600 252,199 01/13/23
Buchanan Lucas W. COO/CFO COO/CFO Dec 13 Option 1.6 40,000 64,000 191,527 12/15/22
Buchanan Lucas W. COO/CFO COO/CFO Dec 13 Sell 55 25,000 1,375,000 176,527 12/15/22
Chou Tony M. Director Director Dec 13 Sell 55 10,060 553,300 88,715 12/15/22
Rogers Erica J. President and CEO President and CEO Dec 12 Option 1.6 10,000 16,000 256,199 12/14/22
Rogers Erica J. President and CEO President and CEO Dec 12 Sell 53.85 10,000 538,500 246,199 12/14/22
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Nov 01 Option 1.46 6,753 9,859 104,958 11/01/22
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Nov 01 Sell 44.17 6,753 298,280 98,205 11/01/22
Rogers Erica J. President and CEO President and CEO Sep 12 Option 1.6 10,000 16,000 256,199 09/14/22